Interferons and cell growth control

Histology and Histopathology

Volumn 15, Issue 2, 2000, Pages 523-537

  Kalvakolanu, Dhananjaya V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cancer; Cytokines; Gene regulation; Signaling

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BIOLOGICAL FACTOR; CYTOKINE; GAMMA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; JANUS KINASE; RNA; STAT PROTEIN;

APOPTOSIS; CANCER; CELL COMMUNICATION; CELL CYCLE; CELL GROWTH; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GROWTH REGULATION; HUMAN; NONHUMAN; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; REVIEW; RNA DEGRADATION;

ANIMALS; APOPTOSIS; CELL DIVISION; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

JANUS; VERTEBRATA;

EID: 0034003503     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (198)

1. Ackrill A.M., Foster G.R., Laxton C.D., Flavell D.M., Stark G.R. and Kerr I.M. (1991). Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19, 4387-4393.
2. Adams J.M. and Cory S. (1998). The Bcl-2 protein family: Arbites of cell survival. Science 281, 1322-1325.
3. Alcami A. and Smith G.L. (1995). Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol. Today 16, 474-478.
4. Aman P. and von Gabain A. (1990). An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines. EMBO J. 9, 147-152.
5. Ashkenazi A. and Dixit V.M. (1998). Death receptors: Signaling modulation. Science 281, 1305-1308.
6. Au W.C., Moore P.A., Lowther W., Juang Y.T. and Pitha P.M. (1995). Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92, 11657-11661.
7. Bach E.A., Tanner J.W., Marsters S., Ashkenazi A., Aguet M., Shaw A.S. and Schreiber R.D. (1996). Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol. Cell. Biol. 16, 3214-3421.
8. Balachandran S., Kim C.N., Yeh W.C., Mak T.W., Bhalla K. and Barber G.N. (1998). Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17, 6888-6902.
9. Baldwin A.S. Jr. (1997). The NF-kB and IkB proteins: New discoveries and insights. Annu. Rev. Immunol. 14, 649-681.
10. Barbieri G., Velazquez L., Scrobogna M., Fellous M. and Pellegrini S. (1994). Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta. Eur. J. Biochem. 223, 427-435.
11. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D'Andrea A. and Livingston D.M. (1996). Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383, 344-347.
12. Bonni A., Sun Y., Nadal-Vicens M., Bhatt A., Frank D.A., Rozovsky I., Stahl N., Yancopoulos G.D. and Greenberg M.E. (1997). Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278, 477-483.
13. Bovolenta C., Driggers P.H., Marks M.S., Medin J.A., Politis A.D., Vogel S.N., Levy D.E., Sakaguchi K., Appella E., Coligan J.E. and Ozato K. (1994). Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. USA 91, 5046-5050.
14. Briken V., Ruffner H., Schultz U., Schwarz A., Reis L.F., Strehlow I., Decker T. and Staeheli P. (1995). Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol. Cell. Biol. 15, 975-982.
15. Bromberg J.F., Horvath C.M., Wen Z., Schreiber R.D. and Darnell J.E. Jr. (1996). Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. USA 93, 7673-7678.
16. Candotti F., Oakes S.A., Johnston J.A., Notarangelo L.D., O'Shea J.J. and Blaese R.M. (1996). In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J. Exp. Med. 183, 2687-2692.
17. Candotti F., Oakes S.A., Johnston J.A., Giliani S., Schumacher R.F., Mella P., Fiorini M., Ugazio A.G., Badolato R., Notarangelo L.D., Bozzi F., Macchi P., Strina D., Vezzoni P., Blaese R.M., O'Shea J.J. and Villa A. (1997). Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 90, 3996-4003.
18. Carlesso N., Frank D.A. and Griffin J.D (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183, 811-820.
19. Chin Y.E., Kitagawa M., Kuida K., Flavell R.A. and Fu X.Y. (1997). Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17, 5328-5337.
20. Chin Y.E., Kitagawa M., Su W.C., You Z.H., Iwamoto Y. and Fu X.Y. (1996). Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272, 719-722.
21. Chong K.L., Feng L., Schappert K., Meurs E., Donahue T.F., Friesen J.D., Hovanessian A.G. and Williams B.R. (1992). Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11, 1553-1562.
22. Choubey D. and Lengyel P. (1995). Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J. Biol. Chem. 270, 6134-6140.
23. Choubey D., Snoddy J., Chaturvedi V., Toniato E., Opdenakker G., Thakur A., Samanta H., Engel D.A. and Lengyel P. (1989). Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J. Biol. Chem. 264, 17182-17189.
24. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P. and Shuai K. (1997). Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805.
25. 2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 16, 998-1008.
26. Contente S., Kenyon K., Rimoldi D. and Friedman R.M. (1990). Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249, 796-798.
27. Dale T.C., Imam A.M., Kerr I.M. and Stark G.R. (1989). Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proc. Natl. Acad. Sci. USA 86, 1203-1207.
28. Danial N.N., Pernis A. and Rothman P.B. (1995). Jak-STAT signaling induced by the v-abl oncogene. Science 269, 1875-1877.
29. Darnell J.E. Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
30. Darnell J.E. Jr., Kerr I.M. and Stark G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
31. Datta B., Li B., Choubey D., Nallur G. and Lengyel P. (1996). p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J. Biol. Chem. 271, 27544-27555.
32. Dawson M.J., Trapani J.A., Briggs R.C., Nicholl J.K., Sutherland G.R. and Baker E. (1995). The closely linked genes encoding the myeloid nuclear differentiation antigen (MNDA) and IFI16 exhibit contrasting haemopoietic expression. Immunogenetics 41, 40-43.
33. Decker T., Lew D.J., Mirkovitch J. and Darnell J.E. Jr. (1991). Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor. EMBO J. 10, 927-932.
34. Deiss L.P. and Kimchi A. (1991). A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252, 117-120.
35. Deiss L.P., Feinstein E., Berissi H., Cohen O. and Kimchi A. (1995). Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev. 9, 15-30.
36. Deiss L.P., Galinka H., Berissi H., Cohen O. and Kimchi A. (1996). Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15, 3861-3870.
37. Der S.D., Yang Y.L., Weissmann C. and Williams B.R. (1997). A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 3279-3283.
38. Der S.D., Zhou A., Williams B.R.G. and Silverman R.H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 15623-15628.
39. DeYoung K.L., Ray M.E., Su Y.A., Anzick S.L., Johnstone R.W., Trapani J.A., Meltzer P.S. and Trent J.M. (1997). Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene 15, 453-457.
40. Dighe A.S., Richards E., Old L.J. and Schreiber R.D. (1994). Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1, 447-456.
41. Domanski P. and Colamonici O.R. (1996). The type-I interferon receptor. The long and short of it. Cytokine Growth Factor Rev. 7, 143-151.
42. Duncan G.S., Mittrucker H.W., Kagi D., Matsuyama T. and Mak T.W. (1996). The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 184, 2043-2048.
43. Duncan S.A., Zhong Z., Wen Z. and Darnell J.E. Jr. (1997). STAT signaling is active during early mammalian development. Dev. Dyn. 208, 190-198.
44. Durbin J.E., Hackenmiller R., Simon M.C. and Levy D.E. (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
45. Eilers A., Georgellis D., Klose B., Schindler C., Ziemiecki A., Harpur A.G., Wilks A.F. and Decker T. (1995). Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages. Mol. Cell. Biol. 15, 3579-3586.
46. Eisenbeis C.F., Singh H. and Storb U. (1995). Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9, 1377-1387.
47. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S. and Yoshimura A. (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387 921-924.
48. Falvo J.V., Thanos D. and Maniatis T. (1995). Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83, 1101-1111.
49. Firmbach-Kraft I., Byers M., Shows T., Dalla-Favera R. and Krolewski J.J. (1990). tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5, 1329-1336.
50. Fish E.N., Uddin S., Korkmaz M., Majchrzak B., Druker B.J. and Platanias L.C. (1999). Activation of a CrkL-stat5 signaling complex by type I interferons. J. Biol. Chem. 274, 571-573.
51. Foster G.R., Ackrill A.M., Goldin R.D., Kerr I.M., Thomas H.C. and Stark G.R. (1991). Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc. Natl. Acad. Sci. USA 88, 2888-2892.
52. Fujita T., Kimura Y., Miyamoto M., Barsoumian E.L. and Taniguchi T. (1989a). Induction of endogenous IFN-alpna and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 337, 270-272.
53. Fujita T., Reis L.F., Watanabe N., Kimura Y., Taniguchi T. and Vilcek J. (1989b). Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA 86, 9936-9940.
54. Gao S.J., Boshoff C., Jayachandra S., Weiss R.A., Chang Y. and Moore P.S. (1997). KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15, 1979-1985.
55. Gauzzi M.C., Velazquez L., McKendry R., Mogensen K.E., Fellous M. and Pellegrini S. (1996). Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J. Biol. Chem. 271, 20494-20500.
56. Ghislain J., Sussman G., Goelz S., Ling L.E. and Fish E.N. (1995). Configuration of the interferon-alpha/beta receptor complex determines the context of the biological response. J. Biol. Chem. 270, 21785-21792.
57. Greenlund A.C., Farrar M.A., Viviano B.L. and Schreiber R.D. (1994). Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13, 1591-1600.
58. Greenlund A.C., Morales M.O., Viviano B.L., Yan H., Krolewski J. and Schreiber R.D. (1995). Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 2, 677-687.
59. Gupta S., Yan H., Wong L.H., Ralph S., Krolewski J. and Schindler C. (1996). The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals. EMBO J. 15, 1075-1084.
60. Gutch M.J. and Reich N.C. (1991). Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 88, 7913-7917.
61. Hanash S.M., Beretta L., Barcroft C.L., Sheldon S., Glover T.W., Ungar D. and Sonenberg N. (1993). Mapping of the gene for interferon-inducible dsRNA-dependent protein kinase to chromosome region 2p21-22: a site of rearrangements in myeloproliferative disorders. Gene. Chrom. Cancer 8, 34-37.
62. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T. and Taniguchi T. (1989). Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58, 729-739.
63. Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M. and Taniguchi T. (1993). Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259, 971-974.
64. Harada H., Kondo T., Ogawa S., Tamura T., Kitagawa M., Tanaka N., Lamphier M.S., Hirai H. and Taniguchi T. (1994). Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia - A possible mechanism of tumor suppressor inactivation. Oncogene 9, 3313-3320.
65. Haspel R.L., Salditt-Georgieff M. and Darnell J.E. Jr. (1996). The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 15, 6262-6268.
66. Hassel B.A., Zhou A., Sotomayor C., Maran A. and Silverman R.H. (1993). A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12, 3297-3304.
67. Heim M.H., Kerr I.M., Stark G.R. and Darnell J.E. Jr. (1995). Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267, 1347-1349.
68. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E. Metcalf D. and Nicola N.A. (1998). Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95, 114-119.
69. Hobart M., Ramassar V., Goes N., Urmson J. and Halloran P.F. (1997). IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158, 4260-4269.
70. Holtschke T., Lohler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.P., Gabriele L., Waring J., Bachmann M.F., Zinkernagel R.M., Morse H.C., Ozato K. and Horak I. (1996). Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307-317.
71. Horvath C.M., Stark G.R., Kerr I.M. and Darnell J.E. Jr. (1996). Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol. Cell. Biol. 16, 6957-6964.
72. Hovanessian A.G. (1991). Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′,5′-oligoadenylate synthetases. J. Interferon Res. 11, 199-205.
73. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R.M. and Aguet M. (1993). Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742-1745.
74. Hunter T. (1995). Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
75. Hwang S.Y., Hertzog P.J., Holland K.A., Sumarsono S.H., Tymms M.J., Hamilton J.A., Whitty G., Bertoncello I. and Kola I. (1995). A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA 92, 11284-11288.
76. Igarashi K., David M., Lamer A.C. and Finbloom D.S. (1993). In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Mol. Cell. Biol. 13, 3984-3989.
77. Imakawa K., Anthony R.V., Kazemi M., Marotti K.R., Polites H.G. and Roberts R.M. (1987). Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature 330, 377-379.
78. Inbal B., Cohen O., Polak-Charcon S., Kopolovic J., Vadai E., Eisenbach L. and Kimchi A. (1997). DAP kinase links the control of apoptosis to metastasis. Nature 390, 180-184.
79. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.F., Newport M., Levin M., Blanche S., Seboun E., Fischer A. and Casanova J.L. (1996). Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335, 1956-1961.
80. Kalvakolanu D.V. (1999). Virus interception of cytokine regulated pathways. Trends Microbiol. 7, 166-171.
81. Kalvakolanu D.V. and Borden E.G. (1996). An overview of the interferon system: signal transduction and mechanisms of action. Cancer Investig. 14, 25-53.
82. Kalvakolanu D.V., Bandyopadhyay S.K., Harter M.L. and Sen G.C. (1991). Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: Block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88, 7459-7463.
83. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.I., Kimura T., Green S.J., Mak T.W., Taniguchi T. and Vilcek J. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
84. Kao W.Y., Briggs J.A., Kinney M.C., Jensen R.A. and Briggs R.C. (1997). Structure and function analysis of the human myeloid cell nuclear differentiation antigen promoter: evidence for the role of Sp1 and not of c-Myb or PU.1 in myelomonocytic lineage-specific expression. J. Cell. Biochem. 65, 231-44.
85. Kaplan D.H., Greenlund A.C., Tanner J.W., Shaw A.S. and Schreiber R.D. (1996). Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding. J. Biol. Chem. 271, 9-12.
86. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J. and Schreiber R.D. (1998). Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561.
87. Kaplan M.H., Sun Y.L., Hoey T. and Grusby M.J. (1996). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
88. Kim T.K. and Maniatis T. (1996). Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 273, 1717-1719.
89. Kimchi A. (1992). Cytokine triggered molecular pathways that control cell cycle arrest. J. Cell. Biochem. 50, 1-9.
90. Kimura T., Kadokawa Y., Harada H., Matsumoto M., Sato M., Kashiwazaki Y., Tarutani M., Tan R.S., Takasugi T., Matsuyama T., Mak T.W., Noguchi S. and Taniguchi T. (1996). Essential and non-redundant roles of p48 (ISGFSγ) in both type I and type II interferon responses, as revelad by gene targeting studies. Genes Cells 1, 115-124.
91. Kirken R.A., Rui H., Malabarba M.G. and Farrar W.L. (1994). Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. J. Biol. Chem. 269, 19136-19141.
92. Kissil J.L., Deiss L.P., Bayewitch M., Raveh T., Khaspekov G. and Kimchi A. (1995). Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death. J. Biol. Chem. 270, 27932-27936.
93. Kissil J.L., Feinstein E., Cohen O., Jones P.A., Tsai Y.C., Knowles M.A., Eydmann M.E. and Kimchi A. (1997). DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 15, 403-407.
94. Koch C.A., Anderson D., Moran M.F., Ellis C. and Pawson T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674.
95. Koromilas A.E., Roy S., Barber G.N., Katze M.G. and Sonenberg N. (1992). Malignant transformation by a mutant of the IFN-inducible dsRNA dependent protein kinase. Science 257, 1685-1689.
96. Kumar R. and Atlas I. (1992). Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation. Proc. Natl. Acad. Sci. USA 89, 6599-6603.
97. Kumar A., Hague J., Lacoste J., Hiscott J. and Williams B.R. (1994). Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA 91, 6288-6292.
98. Kumar A., Commane M., Flickinger T.W., Horvath C.M. and Stark G.R. (1997a). Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278, 1630-1632.
99. Kumar A., Yang Y.L., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissmann C. and Williams B.R. (1997b). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16, 406-416.
100. Lacronique V., Boureux A., Valle V.D., Poirel H., Quang C.T., Mauchauffe M., Berthou C., Lessard M., Berger R., Ghysdael J. and Bernard O.A. (1997). A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278, 1309-1312.
101. Lai K.S., Jin Y., Graham D.K., Witthuhn B.A., Ihle J.N. and Liu E.T. (1995). A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells. J. Biol. Chem. 270, 25028-25036.
102. Leonard G.T. and Sen G.G. (1997). Restoration of interferon responses of adenovirus E1A-expressiing HT1080 cell lines by overexpression of p48 protein. J. Virol .71, 5095-5101.
103. Leung S., Qureshi S.A., Kerr I.M., Darnell J.E. Jr. and Stark G.R. (1995). Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15, 1312-1317.
104. Levy D.E., Kessler D.S., Pine R. and Darnell J.E. Jr. (1989). Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 3, 1362-1371.
105. Levy-Strumpf N., Deiss L.P., Berissi H. and Kimchi A. (1997). DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death. Mol. Cell. Biol. 17, 1615-1625.
106. Lin R., Heylbroeck C., Pitha P.M. and Hiscott J. (1998). Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986-2996.
107. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A. and Hennighausen L. (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186.
108. Lobie P.E., Ronsin B., Silvennoinen O., Haldosen L.A., Norstedt G. and Morel G. (1996). Constitutive nuclear localization of Janus kinases 1 and 2. Endocrinology 137, 4037-4045.
109. Lohoff M., Ferrick D., Mittrucker H.W., Duncan G.S., Bischof S., Rollinghoff M. and Mak T.W. (1997). Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6, 681-689.
110. Lund T.C., Garcia R., Medveczky M.M., Jove R. and Medveczky P.G. (1997). Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck. J. Virol. 71, 6677-6782.
111. Lutfalla G., Holland S.J., Cinato E., Monneron D., Reboul J., Rogers N.C., Smith J.M., Stark G.R., Gardiner K. and Mogensen K.E. (1995). Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14, 5100-5108.
112. Maran A., Waller C.F., Paranjape J.M., Li G., Xiao W., Zhang K., Kalaycio M.E., Maitra R.K., Lichtin A.E., Brugger W., Torrence P.F. and Silverman R.H. (1998). 2′,5′-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells. Blood 92, 4336-4343.
113. Marsters S.A., Pennica D., Bach E., Schreiber R.D. and Ashkenazi A. (1995). Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc. Natl. Acad. Sci. USA 92, 5401-5405.
114. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T.M., Amakawa R., Kishihara K. and Wakeham A. (1993). Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83-97.
115. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M. and Schreiber R.D. (1996). Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
116. Meurs E., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R. and Hovanessian A.G. (1990). Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390.
117. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., Levitzki A. and Roifman C.M. (1996). Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645-648.
118. Mignoe T.-S., Lin J.-X., Cereseto A., Mulloy J.C., O'Shea J.J., Franchini G. and Leonard W.J. (1995). Constitutively activated Jak-STAT pathway in T-cells transformed with HTLV-I. Science 269, 79-81.
119. Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman J.W. and Sedmak D.D. (1998). Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187, 675-683.
120. Mittrucker H.W., Matsuyama T., Grossman A., Kundig T.M., Potter J., Shahinian A., Wakeham A., Patterson B., Ohashi P.S. and Mak T.W. (1997). Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543.
121. Moore P.S., Boshoff C., Weiss R.A. and Chang Y. (1996). Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744.
122. Mouchel-Vielh E., Lutfalla G., Mogensen K.E. and Uze G. (1992). Specific antiviral activities of the human alpha interferons are determined at the level of receptor (IFNAR) structure. FEBS Lett. 313, 255-259.
123. Muller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O., Harpur A.G., Barbieri G., Witthuhn B.A., Schindler C., Pellegrini S., Wilks A.F., Ihle J.N., Stark G.R. and Kerr I.M. (1993a). The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366, 129-135.
124. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell, J.E., Jr., Stark G.R. and Kerr I.M. (1993b). Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12, 4221-4228.
125. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M. and Aguet M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
126. Mundschau L.J. and Faller D.V. (1995). Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J. Biol. Chem. 270, 3100-3106.
127. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S. and Kishimoto T. (1997). Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929.
128. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y., Saito H., Nagasawa T., Uchiyama Y. and Kishimoto T. (1998). Accelerated apoptosis of lymphocytes by augmented induction of bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95, 15577-15582.
129. Nelson N., Marks M.S., Driggers P.H. and Ozato K. (1993). Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol. 13, 588-599.
130. Neubauer H., Cumano A., Muller M., Wu H., Huffstadt U. and Pfeffer K. (1998). Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93, 397-409.
131. Newport M.J., Huxley C.M., Huston S. Hawrylowicz C.M., Oostra B.A., Williamson R. and Levin M. (1996). A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941-1949.
132. Nosaka T., van Deursen J.M., Tripp R.A., Thierfelder W.E., Witthuhn B.A., McMickle A.P., Doherty P.C., Grosveld G.G. and Ihle J.N. (1995). Defective lymphoid development in mice lacking Jak3. Science 270, 800-802.
133. Parganas E., Wang D., Stravopodis D., Topham D.J., Marine J.C., Teglund S., Vanin E.F., Bodner S., Colamonici O.R., van Deursen J.M., Grosveld G. and Ihle J.N. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385-395.
134. Peeters P., Raynaud S.D., Cools J., Wlodarska I., Grosgeorge J., Philip P., Monpoux F., Van Rompaey L., Baens M., Van den Berghe H. and Marynen P. (1997). Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90, 2535-2540.
135. Pestka S. (1997). The interferon receptors. Semin. Oncol. 24, S9-S40.
136. Petricoin E. Jr., David M., Fang H., Grimley P., Larner A.C. and Vande Pol S. (1994). Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins. Mol. Cell. Biol. 14, 1477-1486.
137. Pfeffer L.M., Mullersman J.E., Pfeffer S.R., Murti A., Shi W. and Yang C.H. (1997). STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276, 1418-1420.
138. Pine R., Decker T., Kessler D.S., Levy D.E. and Darnell J.E. Jr. (1990). Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10, 2448-2457.
139. Qureshi S.A., Leung S., Kerr I.M., Stark G.R. and Darnell J.E. Jr. (1996). Function of Stat2 protein in transcriptional activation by alpha interferon. Mol. Cell. Biol. 16, 288-293.
140. Qureshi S.A., Salditt-Georgieff M. and Darnell J.E. Jr. (1995). Tyrosine phsophorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated gene factor 3. Proc. Natl. Acad. Sci. USA 92, 3829-3833.
141. Rane S.G. and Reddy E.P. (1994). JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene 9, 2415-2423.
142. Reis L.F., Harada H., Wolchok J.D., Taniguchi T. and Vilcek J. (1992). Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J. 11, 185-193.
143. Resnitzky D., Tiefenbrun N., Berissi H. and Kimchi A. (1992). Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA 89, 402-406.
144. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C., Yin L., Pennica D., Johnson E.M. Jr. and Schreiber R.D. (1998). Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373-383.
145. Russell S.M., Tayebi N., Nakajima H., Riedy M.C., Roberts J.L., Aman M.J., Migone T.S., Noguchi M., Markert M.L. and Buckley R.H. (1995). Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797-800.
146. Rutherford M.N., Kumar A., Nissim A., Chebath J. and Williams B.R. (1991). The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucl. Acids Res. 19, 1917-1924.
147. Sakatsume M., Igarashi K., Winestock K.D., Garotta G., Larner A.C. and Finbloom D.S. (1995). The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J. Biol. Chem. 270, 17528-17534.
148. Salzberg S., Hyman T., Turm H., Kinar Y., Schwartz Y., Nir U., Lejbkowicz F. and Huberman E. (1997). Ectopic expression of 2-5A synthetase in myeloid cells induces growth arrest and facilitates the appearance of a myeloid differentiation marker. Cancer Res. 57, 2732-2740.
149. Schmidt M., Nagel S., Proba J., Thiede C., Ritter M., Waring J.F., Rosenbauer F., Huhn D., Wittig B., Horak I. and Neubauer A. (1998). Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91, 22-29.
150. Sen G.C. and Ransohoff R.M. (1997). Transcriptional regulation in the interferon system. Chapman & Hall and Landes Bioscience. Austin, TX.
151. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., Chu C., Quelle F.W., Nosaka T., Vignali D.A., Doherty P.C., Grosveld G., Paul W.E. and Ihle J.N. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
152. Shuai K., Halpern J., ten Hoeve J., Rao X. and Sawyers C.L. (1996).
153. Shuai K., Stark G.R., Kerr I.M. and Darnell J.E. Jr. (1993). A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261, 1744-1746.
154. Shuai K., Horvath C.M., Huang L.H., Qureshi S.A., Cowburn D. and Darnell J.E. Jr. (1994). Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76, 821-828.
155. Silverman R. H. (1997). 2-5A dependent Rnase L: a regulated endoribonuclease in the interferon system. In: Rinonucleases: Structure and functions. D'Alessio G. and Riordan J.F. (eds). Academic Press. New York, pp 515-551.
156. Stahl N. and Yancopoulos G.D. (1994). The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines. J. Neurobiol. 25, 1454-1466.
157. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H. and Schreiber R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
158. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A. and Hilton D.J. (1997). A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921.
159. Su W.C., Kitagawa M., Xue N., Xie B., Garofalo S., Cho J., Deng C., Horton W.A. and Fu X.Y. (1997). Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386, 288-292.
160. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T. and Akira S. (1997). Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94, 3801-3804.
161. Takemoto S., Mulloy J.C., Cereseto A., Migone T.S., Patel B.K., Matsuoka M., Yamaguchi K., Takatsuki K., Kamihira S., White J.D., Leonard W.J., Waldmann T. and Franchini G. (1997). Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA 94, 13897-13902.
162. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., Suzuki G., Mitsuyama M., Shin E.H., Kojima S., Taniguchi T. and Asano Y. (1997). Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6, 673-679.
163. Tamura T., Ishihara M., Lamphier M.S., Tanaka N., Oishi I., Aizawa S., Matsuyama T., Mak T.W., Taki S. and Taniguchi T. (1995). An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376, 596-599.
164. Tan R.S., Taniguchi T. and Harada H. (1996). Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res. 56, 2417-2421.
165. Tanaka N., Ishihara M., Kitagawa M., Harada H., Kimura T., Matsuyama T., Lamphier M.S., Aizawa S., Mak T.W. and Taniguchi T. (1994). Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77, 829-839.
166. Tanaka N., Ishihara M., Lamphier M.S., Nozawa H., Matsuyama T., Mak T.W., Aizawa S., Tokino T., Oren M. and Taniguchi T. (1996). Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382, 816-818.
167. Taniguchi T., Lamphier M.S. and Tanaka N. (1997). IRF1: the transcription factor linking interferon response and oncogenesis. Biochim. Biophys. Acta 1333, M9-M17.
168. Tannenbaum C.S., Major J., Ohmori Y. and Hamilton T.A. (1993). A lipopolysaccharide-inducible macrophage gene (D3) is a new member of an interferon-inducible gene cluster and is selectively expressed in mononuclear phagocytes. J. Leukoc. Biol. 53, 563-568.
169. Thanos D. and Maniatis T. (1995). Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100.
170. Thornberry N.A. and Lazebnik Y. (1998). Caspases: Enemies within. Science 281, 1312-1316.
171. Uze G., Lutfalla G. and Gresser I. (1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
172. Vaughan P.S., Aziz F., van Wijnen A.J., Wu S., Harada H., Taniguchi T., Soprano K.J., Stein J.L. and Stein G.S. (1995). Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature 377, 362-365.
173. Veals S.A., Schindler C., Leonard D., Fu X.Y., Aebersold R., Darnell J.E. Jr. and Levy D.E. (1992). Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 12, 3315-3324.
174. Velazquez L., Fellous M., Stark G.R. and Pellegrini S. (1992). A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70, 313-322.
175. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M. and Maniatis T. (1998). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1, 507-518.
176. Watling D., Guschin D., Muller M., Silvennoinen O., Witthuhn B.A., Quelle F.W., Rogers N.C., Schindler C., Stark G.R. and Ihle J.N. (1993). Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366, 166-170.
177. Weaver B.K., Kumar K.P. and Reich N.C. (1998). Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18, 1359-1368.
178. Weihua X., Lindner D.J. and Kalvakolanu D.V. (1997). The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc. Proc. Natl. Acad. Sci. USA 94, 7227-7232.
179. Weihua X., Ramanujam S., Lindner D.J., Kudaravalli R.D., Freund R. and Kalvakolanu D.V. (1998). The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc. Natl. Acad. Sci. U S A 95, 1085-1090.
180. Wen Z., Zhong Z. and Darnell J.E. Jr. (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
181. White L.C., Wright K.L., Felix N.J., Ruffner H., Reis L.F., Pine R. and Ting J.P. (1996). Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/-mice. Immunity 5, 365-376.
182. Whitten T.M., Quets A.T. and Schloemer R.H. (1991). Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J. Virol. 65, 4699-4704.
183. Wilks A.F. (1991). Cloning members of protein-tyrosine kinase family using polymerase chain reaction. Methods Enzymol. 200, 533-546.
184. Williams B.R. (1997). Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 25, 509-513.
185. Willman C.L., Sever C.E., Pallavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F. and Taniguchi T. (1993). Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259, 968-971.
186. Witthuhn B.A., Silvennoinen O., Miura O., Lai K.S., Cwik C., Liu E.T. and Ihle J.N. (1994). Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370, 153-157.
187. Xie J., Briggs J.A., Morris S.W., Olson M.O., Kinney M.C. and Briggs R.C. (1997). MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia. Exp. Hematol. 25, 1111-1117.
188. Xu X., Kang S.H., Heidenreich O., Okerholm M., O'Shea J.J. and Nerenberg M.I. (1995). Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J. Clin. Invest. 96, 1548-1555.
189. Yamagata T., Nishida J., Tanaka S., Sakai R., Mitani K., Yoshida M., Taniguchi T., Yazaki Y. and Hirai H. (1996). A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16, 1283-1294.
190. Yan H., Krishnan K., Lim J.T., Contillo L.G. and Krolewski J.J. (1996). Molecular characterization of an alpha interferon receptor 1 subunit (IFNαR1) domain required for TYK2 binding and signal transduction. Mol. Cell. Biol. 16, 2074-2082.
191. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E. and Fujita T. (1998). Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087-1095.
192. Young H.A. and Ghosh P. (1997). Molecular regulation of cytokine gene expression: interferon-gamma as a model system. Prog. Nucl. Acid Res. Mol. Biol. 56, 109-127.
193. Yu C.L., Meyer D.J., Campbell G.S., Larner A.C., Carter-Su C., Schwartz J. and Jove R. (1995). Enhanced DNA-binding activity of a Stat5-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83.
194. Zhang L. and Pagano J.S. (1997). IRF-7, a new interferon regulatory factor associated with Epstein-Barr Virus latency. Mol. Cell. Biol. 17, 5748-5757.
195. Zhang X., Blenis J., Li H.C., Schindler C. and Chen-Kiang S. (1995). Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267, 1990-1994.
196. Zhou A., Hassel B.A. and Silverman R.H. (1993). Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72, 753-765.
197. Zhou A., Paranjape J., Brown T.L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R., Colmenares C. and Silverman R.H. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16, 6355-6363.
198. Zimring J.C., Goodbourn S. and Offermann M.K. (1998). Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 72, 701-707.